Taiwan FDA registration acd14b76ee4fdac67443ad1e82a66e8e
ImmunoCAP Specific IgE Negative Control
TW: 英尤凱特異性IgE陰性品管液
Taiwan·Risk Class 2·MD·PHADIA AB·Registered Aug 11, 2015 – Aug 11, 2025ExpiredRegistration details
- Analysis ID
- acd14b76ee4fdac67443ad1e82a66e8e
- License Form
- Ministry of Health Medical Device Import No. 027551
- Customs Code
- DHA05602755101
Company information
- Manufacturer
- PHADIA AB
- Manufacturer Country
- Sweden
- Authorized Representative
- PHADIA TAIWAN INC.
Product details
- Intended Use
- This product is used to monitor the performance of Inyokai-specific IgE analysis on Fadi series instruments.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A1660 Quality Control Materials (Analytical and Non-Analytical)
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Aug 11, 2015
- Expiry Date
- Aug 11, 2025
About this record
Access comprehensive regulatory information for ImmunoCAP Specific IgE Negative Control in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number acd14b76ee4fdac67443ad1e82a66e8e and manufactured by PHADIA AB. The authorized representative in Taiwan is PHADIA TAIWAN INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices